5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies
Clinical trial NCT04187703 · RECRUITING
Trial details
- NCT number
- NCT04187703
- Sponsor
- Benjamin Tomlinson
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-16
- Primary completion
- 2026-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.